Transforming growth factor β signalling in vitro and in vivo: Activin ligand-receptor interaction, Smad5 in vasculogenesis, and repression of target genes by the δEF1/ZEB-related SIP1 in the vertebrate embryo

Molecular and Cellular Endocrinology

Volumn 180, Issue 1-2, 2001, Pages 13-24

  Zwijsen, An ^a   Van Grunsven, Leo A ^a   Bosman, Erika A ^a   Collart, Clara ^a   Nelles, Luc ^a   Umans, Lieve ^a   Van de Putte, Tom ^a   Wuytens, Gunther ^a   Huylebroeck, Danny ^a   Verschueren, Kristin ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Activin; Angiogenesis; Bone morphogenetic protein; Brachyury; Smad; Smad interacting protein

Indexed keywords

ACTIVIN A; BONE MORPHOGENETIC PROTEIN; INHIBIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; BINDING SITE; CONFERENCE PAPER; EMBRYO; ENDOTHELIUM CELL; GENE EXPRESSION; GENE REPRESSION; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MORPHOLOGY; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; VERTEBRATE; XENOPUS; YOLK SAC;

ACTIVIN RECEPTORS; ACTIVINS; ANIMALS; DNA-BINDING PROTEINS; DRUG INTERACTIONS; HOMEODOMAIN PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOPROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SMAD5 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; VERTEBRATES;

EID: 0035974426     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(01)00505-6     Document Type: Conference Paper

References (87)

1. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2
2. Endodermal Nodal-related signals and mesoderm induction in Xenopus
3. The Drosophila schnurri gene acts in the Dpp/TGFbeta signaling pathway and encodes a transcription factor homologous to the human MBP family
4. Endoglin, an ancillary TGFbeta receptor is required for extraembryonic angiogenesis and plays a key role in heart development
5. Mads and Smads in TGF beta signalling
6. Smads as transcriptional co-modulators
7. Role of transforming growth factor beta in human disease
8. The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions
9. The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A
10. The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis
11. Mechanisms of left-right determination in vertebrates
12. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects
13. Smad5 is essential for left-right asymmetry in mice
14. Structure and expression of a membrane component of the inhibin receptor system
15. The zinc finger protein schnurri acts as a Smad partner in mediating the transcriptional response to decapentaplegic
16. BMP signalling in early Xenopus development
17. Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily
18. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knockout mice
19. Bmp-4 acts as a morphogen in dorsoventral mesoderm patterning in Xenopus
20. Oocyte-expressed TGF-beta superfamily members in female fertility
21. Primary structure requirements for Xenopus nodal-related 3 and a comparison with regions required by Xenopus nodal-related 2
22. The role for transforming growth factor-beta (TGF-beta) in human cancer
23. Engagement of bone morphogenetic protein type 1B receptor and Smad1 signaling by anti-Mullerian hormone and its type II receptor
24. Functional analysis of the TGFbeta receptor/Smad pathway though gene ablation in mice
25. Transforming growth factor-β signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice
26. Endoderm development: from patterning to organogenesis
27. Identification of a binding site on the type II activin receptor for activin and inhibin
28. Schnurri is required for Drosophila Dpp signaling and encodes a zinc finger protein similar to the mammalian transcription factor PRDII-BF1
29. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily
30. Neural induction
31. TGF-beta signalling from cell membrane to nucleus through SMAD proteins
32. An active site of transforming growth factor-beta(1) for growth inhibition and stimulation
33. Reiterative signaling and patterning during mammalian tooth morphogenesis
34. Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity
35. Vertebrate mesendoderm induction and patterning
36. Crystal structure of the BMP-2-BRIA ectodomain complex
37. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II
38. The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis
39. Transgenic approaches to study the function of the transforming growth factor-β superfamily members
40. The Xenopus Brachyury promoter is activated by FGF and low concentrations of activin and suppressed by high concentrations of activin and by paired-type homeodomain proteins
41. Region-specific activation of the Xenopus brachyury promoter involves active repression in ectoderm and endoderm: a study using transgenic frog embryos
42. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling
43. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor
44. Functional analysis of the cysteine residues of activin A
45. TGF-beta signal transduction
46. Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals
47. Controlling TGF-beta signaling
48. Transcriptional control by the TGF-beta/Smad signaling system
49. TGFbeta signaling in growth control, cancer, and heritable disorders
50. The C-terminal domain of Mad-like signal transducers is sufficient for biological activity in the Xenopus embryo and transcriptional activation
51. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis
52. Positive and negative regulation of TGF-beta signaling
53. Developmental tumors, early differentiation and the transforming growth factor β superfamily
54. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5
55. Smad2 role in mesoderm formation, left-right patterning and craniofacial development
56. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis
57. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis
58. Mutations in CDMP1 cause autosomal dominant brachydactyly type C
59. Differential expression and function of members of the zfh-1 family of zinc finger/homeodomain repressors
60. Distinct functional domains of TGF-beta bind receptors on endothelial cells
61. New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites
62. Expression of ALK-1, a type 1 serine/threonine kinase receptor, coincides with sites of vasculogenesis and angiogenesis in early mouse development
63. An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2
64. Two mechanisms in the action of repressor deltaEF1: binding site competition with an activator and active repression
65. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo
66. Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family
67. Smad5 induces ventral fates in the Xenopus embryo
68. DeltaEF1, a zinc finger and homeodomain transcription factor, is required for skeleton patterning in multiple lineages
69. Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase
70. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1
71. Schnurri interacts with Mad in a Dpp-dependent manner
72. Arteriovenous malformations in mice lacking activin receptor-like kinase-1
73. XSIP1, a Xenopus zinc finger/homeodomain encoding gene highly expressed during early neural development
74. Remarkable versatility of Smad proteins in the nucleus of transforming growth factor-beta activated cells
75. SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5′-CACCT sequences in candidate target genes
76. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo
77. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2
78. Concentration-dependent patterning of the Xenopus ectoderm by BMP4 and its signal transducer Smad1
79. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse
80. Regulation of Smad activity
81. Identification of two amino acids in activin A that are important for biological activity and binding to the activin type II receptors
82. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism
83. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects
84. The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice
85. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development
86. Regulation of Smad signalling by protein associations and crosstalk